Covance Inc. - one of the world's largest and most comprehensive drug development services companies - has the people, global resources and problem-solving culture to respond to pharmaceutical and biotechnology clients' toughest drug development challenges.

We provide a portfolio of preclinical and clinical development and commercial service offerings - delivered through industry-leading nonclinical testing services, the world's largest central laboratory network, and a global team of clinical trial professionals and cardiac safety experts. With headquarters in Princeton, New Jersey, Covance Inc. has global operations in 20 countries and approximately 8,900 employees worldwide.

Strategic partnerships built on decades of success - Covance is dedicated to helping bring your miracles to market sooner.

CTMS, Inc., a privately held CRO, provides the complete scope of clinical trial management, data management, regulatory and feasibility services for the pharmaceutical, bio-tech and medical device industries.   Our full-service and task-based capabilities extend to clients throughout North America and Europe.  Our metrics reveal our distinctives, a few of which are summarized below:
96% of all studies have been completed without a CTMS-initiated Change in Scope
Our satisfied client repeat and/or referred business averages 97%
Company-wide cumulative retention rate averages 94% for the last 5 years. 
Extraordinarily low database error rate of .0007536
Since 1989, CTMS has provided quality-centered services to Top 10 pharmaceutical, biotechnology, mid-sized and specialty pharma companies.  Discover why CTMS is A Refreshingly Different CRO.  

For more than two decades, INC Research has been a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity.  Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I - Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials. Our Trusted Process™ methodology and therapeutic foresight leads our customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina, with 25 offices and a presence in 36 locations worldwide. Whether the scope of your project is a full-service international study or requires only select regional services, INC Research can meet your needs.

Paragon Biomedical specializes in bringing innovation to market through impeccably managed Phase I-IV clinical trials management. Our global teams of highly experienced professionals bring localized expertise and a team-first mindset to every project. With an unwavering, company-wide commitment to excellence, we are dedicated to the success of your project.

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1,200 people with 23 offices across the Americas, Europe, Latin America and in India. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions.

Cmed is a full service CRO combining world-class 21st Century technology with exceptional industry experience that offers a unique approach to clinical research and data capture/management that delivers real advantages to its clients. Cmed has engineered and patented a single database system to handle all aspects of the acquisition, management, review and reporting of clinical data program level. From its offices in the US and Europe, Cmed has provided its clients with high quality services and products at competitive prices.

About Cognizant's Life Science Practice

Cognizant's Life Science Practice partners today with 27 of the top 30 global pharmaceutical/biotech organizations in addition to serving the medical devices, CRO and life sciences product companies to deliver high value Information Technology and Business Process Outsourcing services. Cognizant (NASDAQ: CTSH) is a $2.2B USD company based in Teaneck, NJ. With more than 40 global delivery centers and over 58,000 employees, we combine a unique onsite/offshore delivery model infused by a distinct culture of customer satisfaction.

Eurofins Medinet is a leading global central laboratory dedicated to providing fast, efficient, and reliable laboratory testing services to make your drug development efforts a success.  With over 20 years experience, Eurofins Medinet serves the pharmaceutical industry by providing unsurpassed quality standards in laboratory testing, data management, logistics services, and project management.  Other comprehensive services include bioanalysis, biomarker development, genomic testing, and anti-infective services to support simple to complex clinical trials

Formed in 2001 as the for-profit extension of the Ischemia Research and Education Foundation (IREF) – an organization with 20 years of experience in cardiovascular clinical studies – Gentiae is a global leader in comprehensive cardiac safety assessment. Gentiae delivers centralized ECG core lab and imaging services to clients whose clinical trials demand the highest levels of experience and quality clinical interpretation in the analysis of their drug's cardiac safety and functional risk. Leveraging its industry-leading reproducibility and clinical experience, Gentiae is able to deliver tangible value to clients through efficient, cost effective cardiac safety and functional studies in all phases of development.

Kendle is a leading global clinical research organization providing full range early- to late-stage clinical development services for the world’s biopharmaceutical industry. We focus on innovative solutions that reduce cycle times for customers and accelerate delivery of life-enhancing drugs to market. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning 90 countries, along with industry- leading patient access and retention capabilities and broad therapeutic expertise.

PAREXEL International is a leading global bio/pharmaceutical services organization that helps advance healthcare discoveries by providing expertise to the pharmaceutical, biotech and medical device industries throughout the product cycle from drug development and regulatory consulting, to clinical pharmacology, through clinical research, to product commercialization, medical education and reimbursement. This expertise is enhanced by advanced technology solutions, including medical imaging, Clinical Trial Management Systems, Interactive Voice Response Systems and integration services.

PSI is a leading full-service CRO specializing in clinical drug development with offices across Europe and North America. PSI is distinguished by a solid presence and expertise in Eastern Europe, the region that has become a significant contributor of pivotal clinical trial data to global drug development programs.

Quest Diagnostics Clinical Trials consists of 600 employees dedicated to
central laboratory services for Phase II - IV clinical trials.  Laboratories
are located in the United States, United Kingdom and India.  Additionally,
Clinical Trials operates a project management office in Wavre, Belgium and
affiliate laboratories in Singapore, Melbourne and Shanghai.

Reliance Clinical Research Services (RCRS) is a full-service CRO headquartered in Newtown, PA, with core facilities in Mumbai and Bangalore, India. With an organization of over 275 professionals, our services cover the areas of Pre-Clinical, Phase I (including bioequivalence studies), Phases II, III, and IV, Biometrics, Regulatory Affairs, Pharmacovigilence, and Bioanalytical, Diagnostic and Molecular Lab capabilities. The majority of our current clients are US or EU based; we have also successfully completed projects for companies in India, Israel and Japan. For further information, please refer to our website, www.relclin.com.